These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22799366)
21. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194 [TBL] [Abstract][Full Text] [Related]
22. Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells. Nishimura M; Saito T; Yamasaki H; Kudo R Carcinogenesis; 2003 Oct; 24(10):1615-23. PubMed ID: 12896902 [TBL] [Abstract][Full Text] [Related]
23. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370 [TBL] [Abstract][Full Text] [Related]
24. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer. Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426 [TBL] [Abstract][Full Text] [Related]
25. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Chang HW; Chow V; Lam KY; Wei WI; Yuen A Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224 [TBL] [Abstract][Full Text] [Related]
26. Epigenetic down-regulation of death-associated protein kinase in lung cancers. Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953 [TBL] [Abstract][Full Text] [Related]
27. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis. Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757 [TBL] [Abstract][Full Text] [Related]
28. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197 [TBL] [Abstract][Full Text] [Related]
29. Clinical significance of aberrant Wnt7a promoter methylation in human non-small cell lung cancer in Koreans. Kim TH; Moon JY; Kim SH; Paik SS; Yoon HJ; Shin DH; Park SS; Sohn JW J Korean Med Sci; 2015 Feb; 30(2):155-61. PubMed ID: 25653486 [TBL] [Abstract][Full Text] [Related]
30. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers]. Wei WL; Hu HY; Zhang LJ; Chen Y; Ye E; Wang XF Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):532-6. PubMed ID: 22169642 [TBL] [Abstract][Full Text] [Related]
31. [Association of mutation and methylation in the promoter region of TIF1γ with non-small cell lung cancer]. Wang L; Lei Z; Liu X; Liu R; Zhang H Zhongguo Fei Ai Za Zhi; 2013 May; 16(5):227-32. PubMed ID: 23676978 [TBL] [Abstract][Full Text] [Related]
32. WT1 promotes invasion of NSCLC via suppression of CDH1. Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386 [TBL] [Abstract][Full Text] [Related]
33. Does hypermethylation of CpG island in the promoter region of the E-cadherin gene increase the risk of lung cancer? A meta-analysis. Sun Z; Liu G; Xu N Thorac Cancer; 2019 Jan; 10(1):54-59. PubMed ID: 30390382 [TBL] [Abstract][Full Text] [Related]
34. Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5' CpG island. Saito Y; Takazawa H; Uzawa K; Tanzawa H; Sato K Int J Oncol; 1998 Feb; 12(2):293-8. PubMed ID: 9458351 [TBL] [Abstract][Full Text] [Related]
35. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value. Vallböhmer D; Brabender J; Yang D; Schneider PM; Metzger R; Danenberg KD; Hölscher AH; Danenberg PV Clin Lung Cancer; 2006 Jul; 8(1):39-44. PubMed ID: 16870044 [TBL] [Abstract][Full Text] [Related]
36. Detection of promoter hypermethylation of the CpG island of E-cadherin in gastric cardiac adenocarcinoma. Guo W; Dong Z; Guo Y; Kuang G; Yang Z; Chen Z Eur J Med Res; 2009 Sep; 14(10):453-8. PubMed ID: 19748854 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer. Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417 [TBL] [Abstract][Full Text] [Related]
38. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364 [TBL] [Abstract][Full Text] [Related]
39. BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer. Nagji AS; Liu Y; Stelow EB; Stukenborg GJ; Jones DR J Pathol; 2010 Jun; 221(2):229-37. PubMed ID: 20455258 [TBL] [Abstract][Full Text] [Related]
40. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]